EP Patent

EP3854391A1 — Carbamate compound and use of formulation comprising same in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder

Assigned to SK Biopharmaceuticals Co Ltd · Expires 2021-07-28 · 5y expired

What this patent protects

The present invention relates to a use of a pharmaceutical composition comprising the carbamate compound of chemical formula 1 in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder by administering the pharmaceutical composition.

USPTO Abstract

The present invention relates to a use of a pharmaceutical composition comprising the carbamate compound of chemical formula 1 in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder by administering the pharmaceutical composition.

Drugs covered by this patent

Patent Metadata

Patent number
EP3854391A1
Jurisdiction
EP
Classification
—
Expires
2021-07-28
Drug substance claim
No
Drug product claim
No
Assignee
SK Biopharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.